![Nigel Theobald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nigel Theobald
Plus aucun poste en cours
Fortune : 148 756 $ au 31/05/2026
Profil
Nigel James Theobald is the founder of Abaco Capital Plc, founded in 2009.
Mr. Theobald was the founder of N4 Pharma Plc, founded in 2014, and held the title of Chief Executive Officer & Executive Director from 2017 to 2026.
Mr. Theobald was the founder of N4 Pharma UK Ltd., founded in 2014, and held the title of Chief Executive Officer.
Mr. Theobald was a Non-Executive Director at Medherant Ltd. Mr. Theobald was Head-Healthcare Brands at Boots Group Plc.
Mr. Theobald completed undergraduate education at The University of Southampton.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/04/2025 | 16 981 319 ( 2,04% ) | 148 756 $ | 31/05/2026 |
Anciens postes connus de Nigel Theobald
| Sociétés | Poste | Fin |
|---|---|---|
| THALIA THERAPEUTICS PLC | Fondateur | 24/02/2026 |
Boots Group Plc
 Boots Group Plc Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and consumer products | Corporate Officer/Principal | - |
Medherant Ltd.
 Medherant Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery patches | Directeur/Membre du Conseil | - |
N4 Pharma Ltd.
 N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology Operates as a drug reformulation company | Directeur Général | - |
| ABACO CAPITAL PLC | Fondateur | - |
Formation de Nigel Theobald
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Boots Group Plc
Boots Group Plc Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and consumer products | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abaco Capital Plc
 Abaco Capital Plc Financial ConglomeratesFinance Operates as a shell company with no operations | Finance |
N4 Pharma Ltd.
N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology Operates as a drug reformulation company | Health Technology |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery patches | Health Technology |
N4 Pharma Plc
 N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
